tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Neena Bitritto-Garg, 36 are a HOLD (30.25%), 78 are a BUY (65.55%), 5 are a SELL (4.2%).
Analyst Neena Bitritto-Garg, carries an average stock price target met ratio of 56.64% that have a potential upside of 47.85% achieved within 164 days. Previously, Neena Bitritto-Garg worked at DEUTSCHE BANK.
Neena Bitritto-Garg’s has documented 236 price targets and ratings displayed on 20 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 11-Feb-2025.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTIC).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTIC) at 12/12/2023. The price target of $21 was fulfilled within 1 day with a profit of $1.2 (6.06%) receiving and performance score of 60.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2021
$23
$-0.46 (-1.96%)
$22
2 days ago
(06-Feb-2026)
16/17 (94.12%)
$-0.46 (-1.96%)
89
Buy Since 26-Jun-2025
$31
$7.54 (32.14%)
$32
5 days ago
(03-Feb-2026)
0/5 (0%)
$4.87 (18.64%)
Buy Since 21-Oct-2025
$36
$12.54 (53.45%)
$33
1 months 2 days ago
(06-Jan-2026)
0/2 (0%)
$9.06 (33.63%)
Buy Since 17-Oct-2023
$40
$16.54 (70.50%)
$39
1 months 2 days ago
(06-Jan-2026)
2/7 (28.57%)
$13.06 (48.48%)
467
Hold Since 03-Nov-2022
$25
$1.54 (6.56%)
1 months 28 days ago
(11-Dec-2025)
18/21 (85.71%)
$-1.68 (-6.30%)
118
What Year was the first public recommendation made by Neena Bitritto-Garg?
